Medindia

X

Streamline Health Announces Executive Management Change

Friday, November 7, 2008 General News J E 4
Advertisement
CINCINNATI, Nov. 6 Streamline Health Solutions,Inc. (Nasdaq: STRM) today announced that it has notified Paul W. Bridge, Jr.,the Company's Chief Financial Officer, that his employment agreement would notbe renewed upon the expiration of its current term on January 31, 2009.Subsequently, on November 6, 2008, Mr. Bridge unexpectedly informed theCompany that he was resigning from all positions with the Company and itssubsidiaries effective immediately.

The Company intends to conduct a search, considering candidates bothwithin and outside the Company, to replace Mr. Bridge as the Company's ChiefFinancial Officer.

J. Brian Patsy, President and Chief Executive Officer, commenting on theexecutive management change said, "Paul has made significant contributions toStreamline Health over the past 12 years. He has been an integral part of ourexecutive management team and his dedication and loyalty to the Company isunparalleled. We greatly appreciate Paul's service to the Company and we wishhim the best in his future endeavors."

About Streamline Health Solutions, Inc.

Streamline Health is a leading supplier of workflow and documentmanagement tools, applications and services that enable strategic businesspartners and healthcare organizations to improve operational efficienciesthrough business process optimization. The Company provides integratedtechnology solutions for automating document-intensive environments, includingdocument workflow, document management, e-forms, portal connectivity, opticalcharacter recognition (OCR), and interoperability.

Streamline Health's solutions create a permanent document-based repositoryof historical health information that is complementary and can be seamlesslyintegrated with existing disparate clinical, financial and administrativeinformation systems, providing convenient electronic access to all forms ofpatient information from any location, including secure web-based access. Foradditional information, visit our website at http://www.streamlinehealth.net.

"Safe Harbor" statement under the Private Securities Litigation Reform Actof 1995

Statements made by Streamline Health Solutions, Inc. that are nothistorical facts are forward-looking statements that are subject to risks anduncertainties. The forward-looking statements contained herein are subject tocertain risks, uncertainties and important factors that could cause actualresults to differ materially from those reflected in the forward-lookingstatements, included herein. These risks and uncertainties include, but arenot limited to, the timing of the closing of contracts and the timing of thesubsequent revenue recognition related thereto ,the impact of competitiveproducts and pricing, product demand and market acceptance, new productdevelopment, key strategic alliances with vendors that resell the Companyproducts, the ability of the Company to control costs, availability ofproducts produced from third party vendors, the healthcare regulatoryenvironment, healthcare information systems budgets, availability ofhealthcare information systems trained personnel for implementation of newsystems, as well as maintenance of legacy systems, fluctuations in operatingresults and other risks detailed from time to time in the Streamline HealthSolutions, Inc. filings with the U. S. Securities and Exchange Commission.Readers are cautioned not to place undue reliance on these forward-lookingstatements, which reflect management's analysis only as of the date hereof.The Company undertakes no obligation to publicly release the results of anyrevision to these forward-looking statements, which may be made to reflectevents or circumstances after the date hereof or to reflect the occurrence ofunanticipated events.INVESTOR CONTACT: Joe Diaz, Robert Blum Lytham Partners, LLC (602) 889-9700

SOURCE Streamline Health Solutions, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Human Genome Sciences Announces Third Quarter 2008...
S
Genoptix Reports Strong Financial Results for the ...